EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

New Insights into the Development of Papillary Thyroid Cancer: The Roles of miR-1179 and ELF3

Nicolas Henry iD, Nisrine Bahassou, Frédérick Libert, Geneviève Dom, Carine Maenhaut

Cells · 29.04.2026 · 15 (9) · 802

DOI: 10.3390/cells15090802 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 29.04.2026. Verfasst von Nicolas Henry und 4 weiteren Autor:innen. Beteiligte Einrichtung: IRIBHM J. E. Dumont, Université Libre de Bruxelles, 1070 Brussels, Belgium. Hauptthemen laut MEDLINE: MicroRNAs, Thyroid Cancer, Papillary, Transcription Factors, Thyroid Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research credit, Fondation Jaumotte-Demoulin, King Baudouin Foundation, Fund J.P. Naets.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thyroid cancer is the most prevalent endocrine malignancy, and papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. Although the prognosis is generally favorable, a better understanding of the molecular mechanisms involved in this pathology could lead to new treatment opportunities. Dysregulation of miRNA expression has been correlated with tumor development, and miR-1179 has been previously identified as one of the most downregulated miRNAs in PTC. This study aimed to explore the role of miR-1179 in thyroid tumorigenesis. miR-1179 was overexpressed in the TPC-1, B-CPAP, and HTori-3 thyroid cell lines to characterize its function and identify mRNA targets. The relevance of our data for human PTC was then addressed by analyzing TCGA and independent PTC. We showed that miR-1179 triggered apoptosis and inhibited cell migration. We identified ELF3 as a direct target of miR-1179 and other effectors, including NOTCH3 and CX3CL1. Finally, we revealed the existence of an inverse correlation between decreased expression of miR-1179 and increased expression of ELF3, NOTCH3, and CX3CL1 mRNA in human PTC. Our findings suggest that miR-1179 is a tumor suppressor gene and that its loss may contribute to thyroid tumor progression by promoting the expression of ELF3, NOTCH3, and CX3CL1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsThyroid Cancer, PapillaryTranscription FactorsThyroid NeoplasmsDNA-Binding ProteinsProto-Oncogene Proteins c-etsHumansGene Expression Regulation, NeoplasticCell MovementCell Line, TumorApoptosisReceptor, Notch3Carcinogenesis

Stichwörter der Autor:innen

CX3CL1ELF3NOTCH3miR-1179miRNApapillary thyroid carcinomathyroid

Substanzen

MicroRNAsTranscription FactorsDNA-Binding ProteinsELF3 protein, humanProto-Oncogene Proteins c-etsReceptor, Notch3

Autor:innen und Institutionen

  • IRIBHM J. E. Dumont, Université Libre de Bruxelles, 1070 Brussels, Belgium.
  • BRIGHTcore Facility, 1070 Brussels, Belgium.

ORCID-Profile: Nicolas Henry

Förderung

  • Research credit
  • Fondation Jaumotte-Demoulin
  • King Baudouin Foundation, Fund J.P. Naets
  • Fondation Rose et Jean Hoguet
  • Fund for Scientific Research—Research credit
  • King Baudouin Foundation
  • Fondation Rose and Jean Hoguet

Zitieren

APA

Henry, N., Bahassou, N., Libert, F., Dom, G., & Maenhaut, C. (2026). New Insights into the Development of Papillary Thyroid Cancer: The Roles of miR-1179 and ELF3. Cells, 15(9), 802. https://doi.org/10.3390/cells15090802

Vancouver

Henry N, Bahassou N, Libert F, Dom G, Maenhaut C. New Insights into the Development of Papillary Thyroid Cancer: The Roles of miR-1179 and ELF3. Cells. 2026;15(9):802. doi:10.3390/cells15090802

BibTeX
@article{Henry2026,
  author = {Henry, Nicolas and Bahassou, Nisrine and Libert, Frédérick and Dom, Geneviève and Maenhaut, Carine},
  title = {New Insights into the Development of Papillary Thyroid Cancer: The Roles of miR-1179 and ELF3},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {9},
  pages = {802},
  doi = {10.3390/cells15090802}
}
Kostenlos starten →